CVE-2008-4217

Description

Integer signedness error in BOM in Apple Mac OS X before 10.5.6 allows remote attackers to execute arbitrary code via the headers in a crafted CPIO archive, leading to a stack-based buffer overflow.

Category

9.3
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 2.86% Top 15%
Vendor Advisory apple.com Vendor Advisory secunia.com Vendor Advisory apple.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.vupen.com/english/advisories/2008/3444 vdb entry
http://www.us-cert.gov/cas/techalerts/TA08-350A.html third party advisory us government resource
http://www.securityfocus.com/bid/32876 vdb entry
http://secunia.com/advisories/33179 third party advisory vendor advisory
http://www.securitytracker.com/id?1021399 vdb entry
http://www.securityfocus.com/bid/32839 vdb entry
http://support.apple.com/kb/HT3338 vendor advisory
http://lists.apple.com/archives/security-announce//2008//Dec/msg00000.html vendor advisory

Frequently Asked Questions

What is the severity of CVE-2008-4217?
CVE-2008-4217 has been scored as a critical severity vulnerability.
How to fix CVE-2008-4217?
To fix CVE-2008-4217, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-4217 being actively exploited in the wild?
It is possible that CVE-2008-4217 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~3% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.